U.S., July 4 -- ClinicalTrials.gov registry received information related to the study (NCT07050771) titled 'Comprehensive Multimodal Prehabilitation Alone or With Neoadjuvant Therapy Before Major Cancer Surgery' on May 07.
Brief Summary: In this 2-arm, non-randomized, phase II trial, the investigators will evaluate the efficacy and safety of comprehensive multimodal prehabilitation (CMMP) alone or in combination with planned neoadjuvant (NAT) in pre-frail/frail patients with probable/proven pancreaticobiliary, ovarian, kidney, or bladder cancer prior to elective major cancer surgery (EMCS).
Study Start Date: July 01
Study Type: INTERVENTIONAL
Condition:
Hepatopancreaticobiliary (HPB) Malignancy
Ovarian Cancer (OvCa)
Kidney Cancers
Blad...